Literature DB >> 11060960

How to help your patients lose weight: current therapy for obesity.

D Weiss1.   

Abstract

Obesity is epidemic and dangerous. Weight loss is difficult but worth the effort. Although new weight-loss drugs are available, there are no magic bullets: to lose weight and keep it off, people must eat less and exercise more. This article presents a practical approach on how physicians can help their patients lose weight through diet, behavior modification, and adjunctive pharmacologic therapy. An appropriate initial goal is to lose 5% to 10% of one's baseline weight over 3 to 6 months. Drug therapy should not be used in isolation, but it can be an adjunct to diet, exercise, and behavior modification if a patient is committed and able to make necessary changes in eating and activity, and if the patient has a BMI of 30 or higher or a BMI greater than 27 with weight-related comorbid conditions. Anorectic therapy is unlikely to succeed and should be stopped if the patient does not lose at least 4 lb in the first 4 weeks of therapy. Orlistat is unlikely to be of benefit if patients do not lose at least 3% of their baseline weight by 12 weeks. Because obesity is a chronic disease, drug treatment should be continued indefinitely. The physician and patient must understand the intention to treat long-term. The weight loss plan devised should improve upon previous plans: for example, implementing a regular, convenient exercise program that had not been included in the past, or offering pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060960     DOI: 10.3949/ccjm.67.10.739

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  3 in total

1.  The prevalence of overweight adults living in a rural and remote community. The Bella Coola Valley.

Authors:  R Bruce Self; C Laird Birmingham; R Elliott; W Zhang; H V Thommasen
Journal:  Eat Weight Disord       Date:  2005-06       Impact factor: 3.008

2.  Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome.

Authors:  Mark Waterlow; Paul Chrisp
Journal:  Core Evid       Date:  2008-02-29

3.  Weight gain, obesity, and psychotropic prescribing.

Authors:  Nikhil Nihalani; Thomas L Schwartz; Umar A Siddiqui; James L Megna
Journal:  J Obes       Date:  2011-01-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.